However, Huang et al.[7] also showed that high CD147 expression in Type II/III AEGs was significantly associated with cancer tissue types (esophageal cancer versus noncancerous tissues (OR = 11.81, 95%CI = (2.55, 54.64)), poor 3-year survival (OR = 4.05, 95% CI = (1.30, 12.58)), poor 5-year survival (OR = 4.00, 95% CI = (1.46, 10.95)), TNM stage (OR = 4.11, 95% CI = (1.52, 11.14)), lymph node metastasis (OR = 4.40, 95% CI = (1.64, 11.78)), and histological differentiation (OR = 3.30, 95% CI = (1.21, 9.00)). This evidence concerns the gene BSG and cancer.